|
Characteristics
|
Value
|
|---|
|
Response to preoperative chemotherapy
|
0, 1/2, 3
|
69/15
|
|
Age
|
Years
|
65 (30–77)
|
|
Sex
|
F/M
|
14/70
|
|
cT
|
0/1/2/3/4
|
0/11/12/59/2
|
|
cN
|
0/1/2/3
|
10/47/23/4
|
|
cM
|
0/1
|
79/5
|
|
cStage
|
0/1/2/3/4
|
0/3/22/54/5
|
|
pT
|
0/1/2/3/4
|
4/23/19/29/9
|
|
pN
|
0/1/2/3
|
29/28/16/11
|
|
pM
|
0/1
|
79/5
|
|
pStage
|
0/1/2/3/4
|
2/17/27/33/5
|
|
Differentiationa
|
Poor/moderate/well
|
10/59/8
|
|
Lymphatic invasion
|
0/1
|
31/53
|
|
Venous invasion
|
0/1
|
59/25
|
|
Pretreatment serum CEAb
|
ng/ml
|
2.53 (1–6)
|
|
Pretreatment serum SCC antigenc
|
ng/ml
|
1.46 (0.5–6.7)
|
- ESCC esophageal squamous cell carcinoma, CEA carcinoembryonic antigen, SCC squamous cell carcinoma
- aThere were seven cases without information of pathological differentiation
- bThere was one case without serum CEA value
- cThere was one case without serum SCC antigen value
